Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary data on the effectiveness
of the drug for a particular indication or indications in patients with the disease or condition. This phase of testing
also helps determine the common short-term side effects and risks associated with the drug. Phase 2 studies are
typically well-controlled, closely monitored, and conducted in a relatively small number of patients, usually involving
several hundred people.